1. Home
  2. INBX vs RILY Comparison

INBX vs RILY Comparison

Compare INBX & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • RILY
  • Stock Information
  • Founded
  • INBX 2010
  • RILY 1973
  • Country
  • INBX United States
  • RILY United States
  • Employees
  • INBX N/A
  • RILY N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • RILY Investment Managers
  • Sector
  • INBX Health Care
  • RILY Finance
  • Exchange
  • INBX Nasdaq
  • RILY Nasdaq
  • Market Cap
  • INBX 222.5M
  • RILY 185.4M
  • IPO Year
  • INBX 2020
  • RILY 2007
  • Fundamental
  • Price
  • INBX $16.21
  • RILY $5.22
  • Analyst Decision
  • INBX Hold
  • RILY
  • Analyst Count
  • INBX 1
  • RILY 0
  • Target Price
  • INBX N/A
  • RILY N/A
  • AVG Volume (30 Days)
  • INBX 47.7K
  • RILY 2.6M
  • Earning Date
  • INBX 08-13-2024
  • RILY 11-15-2024
  • Dividend Yield
  • INBX N/A
  • RILY 38.91%
  • EPS Growth
  • INBX N/A
  • RILY N/A
  • EPS
  • INBX 118.83
  • RILY N/A
  • Revenue
  • INBX $1,687,000.00
  • RILY $1,221,832,000.00
  • Revenue This Year
  • INBX N/A
  • RILY N/A
  • Revenue Next Year
  • INBX N/A
  • RILY N/A
  • P/E Ratio
  • INBX $0.14
  • RILY N/A
  • Revenue Growth
  • INBX 24.26
  • RILY 19.73
  • 52 Week Low
  • INBX $10.80
  • RILY $4.07
  • 52 Week High
  • INBX $18.95
  • RILY $40.09
  • Technical
  • Relative Strength Index (RSI)
  • INBX 56.54
  • RILY 44.65
  • Support Level
  • INBX $15.24
  • RILY $4.53
  • Resistance Level
  • INBX $16.79
  • RILY $5.70
  • Average True Range (ATR)
  • INBX 0.59
  • RILY 0.49
  • MACD
  • INBX 0.02
  • RILY -0.03
  • Stochastic Oscillator
  • INBX 62.56
  • RILY 27.17

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About RILY B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

Share on Social Networks: